Murray Bornstein

Murray B. Bornstein (November 22, 1917 – August 31, 1995) was an American neuroscientist. He was well known for developing tissue culture techniques valuable for studying demyelinating disease.[1] He was a student of Margaret Ransone Murray, who tuahgt him many of the cell culture techniques critical for his studies. He collaborated with the Weizmann Institute and Teva Pharmaceuticals to develop the drug Copaxone, now a common treatment for multiple sclerosis.[2][3]

In 2014, the Geisel School of Medicine at Dartmouth College established a chaired professorship, relating to research specialty in neurology and multiple sclerosis, in his honor.[4]

References
  1. Bornstein, Murray (1981). "Tissue culture techniques applied to demyelinating disease". Trends in Neurosciences. 4: 237–240. doi:10.1016/0166-2236(81)90074-6. S2CID 53168306. Retrieved 4 March 2017.
  2. Pace, Eric (6 September 1995). "M. B. Bornstein, 77; Known for Research In Multiple Sclerosis". The New York Times. Retrieved 4 March 2017.
  3. "aspetjournals.org". Archived from the original on 2011-05-08.
  4. "Pachner Named Murray B. Bornstein Professor". 13 June 2014. Retrieved 4 March 2017.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.